Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-11 Sale | 2024-03-12 8:01 pm | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 183,238 | $3.1694 | $580,760 | 2,552,499 (Direct) | View |
| 2022-06-23 Purchase | 2022-06-27 06:41 am | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 17,700 | $3.3642 | $59,546 | 1,216,535 (Direct) | View |
| 2019-12-16 Purchase | 2019-12-18 07:35 am | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 20,000 | $5.0954 | $101,908 | 652,216 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-22 Option Award | 2024-05-24 4:53 pm | N/A 2034-05-21 | Evoke Pharma Inc | EVOK | Brady Todd C Director | 14,625 | $0 | 14,625 (Direct) | View |
| 2024-03-09 Option Award | 2024-03-12 8:01 pm | N/A 2034-03-08 | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 1,081,201 | $0 | 2,552,499 (Direct) | View |
| 2023-09-07 Exercise | 2023-09-11 5:42 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 273,058 | $0.552 | 1,654,536 (Direct) | View |
| 2023-09-07 Tax Withholding | 2023-09-11 5:42 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 73,807 | $7.22 | 1,654,536 (Direct) | View |
| 2023-09-07 Exercise | 2023-09-11 5:42 pm | N/A 2023-09-07 | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 273,058 | $0 | 1,654,536 (Direct) | View |
| 2023-05-10 Option Award | 2023-05-11 4:44 pm | N/A 2033-05-09 | Evoke Pharma Inc | EVOK | Brady Todd C Director | 14,625 | $0 | 14,625 (Direct) | View |
| 2023-03-08 Equity Swap | 2023-03-09 09:17 am | N/A N/A | F-star Therapeutics Inc. | FSTX | Brady Todd C Director | 15,004 | $7.12 | 0 (Direct) | View |
| 2020-11-20 Other | 2023-03-09 09:17 am | N/A 2026-07-27 | F-star Therapeutics Inc. | FSTX | Brady Todd C Director | 47,964 | $0 | 0 (Direct) | View |
| 2023-03-08 Disposition | 2023-03-09 09:17 am | N/A 2031-06-04 | F-star Therapeutics Inc. | FSTX | Brady Todd C Director | 40,000 | $0 | 0 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-02 4:22 pm | N/A 2033-02-27 | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 488,750 | $0 | 1,705,285 (Direct) | View |
| 2022-07-15 Option Award | 2022-07-19 4:34 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 604,308 | $0 | 604,308 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 5:15 pm | N/A 2032-06-17 | F-star Therapeutics Inc. | FSTX | Brady Todd C Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-04-27 Option Award | 2022-04-28 7:07 pm | N/A 2032-04-26 | Evoke Pharma Inc | EVOK | Brady Todd C Director | 57,750 | $0 | 57,750 (Direct) | View |
| 2022-03-30 Option Award | 2022-04-01 7:44 pm | N/A 2032-03-29 | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 457,758 | $0 | 1,656,593 (Direct) | View |
| 2021-05-05 Option Award | 2021-07-23 6:15 pm | N/A 2031-05-04 | Evoke Pharma Inc | EVOK | Brady Todd C Director | 57,750 | $0 | 57,750 (Direct) | View |
| 2021-06-04 Option Award | 2021-06-07 4:14 pm | N/A 2031-06-04 | F-star Therapeutics Inc. | FSTX | Brady Todd C Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-04-12 Option Award | 2021-04-14 7:23 pm | N/A 2031-04-11 | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 296,619 | $0 | 1,198,835 (Direct) | View |
| 2020-11-19 Other | 2020-11-23 11:17 am | 2017-05-24 2021-11-23 | F-star Therapeutics Inc. | SBPH | Brady Todd C Director | 2,741 | $0 | 0 (Direct) | View |
| 2020-09-30 Option Award | 2020-10-01 4:00 pm | N/A N/A | Spring Bank Pharmaceuticals Inc. | SBPH | Brady Todd C Director | 9,235 | $0 | 60,016 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-01 4:00 pm | N/A N/A | Spring Bank Pharmaceuticals Inc. | SBPH | Brady Todd C Director | 8,418 | $0 | 50,781 (Direct) | View |
| 2020-06-24 Option Award | 2020-06-25 4:00 pm | N/A 2030-06-23 | Spring Bank Pharmaceuticals Inc. | SBPH | Brady Todd C Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2020-05-27 Option Award | 2020-05-29 4:42 pm | N/A 2030-05-26 | Evoke Pharma Inc | EVOK | Brady Todd C Director | 57,750 | $0 | 57,750 (Direct) | View |
| 2020-03-31 Option Award | 2020-04-01 4:00 pm | N/A N/A | Spring Bank Pharmaceuticals Inc. | SBPH | Brady Todd C Director | 13,306 | $0 | 42,363 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 7:44 pm | N/A 2030-03-01 | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 700,865 | $0 | 1,603,081 (Direct) | View |
| 2019-12-31 Option Award | 2020-01-02 5:09 pm | N/A N/A | Spring Bank Pharmaceuticals Inc. | SBPH | Brady Todd C Director | 7,832 | $0 | 29,057 (Direct) | View |